Table 3.

Clinical outcomes by cohort and for treatment-resistant subgroup. Response, clinical improvement, and remission rates^a

	UC	TMS
		To TMS end	To study end
Total sample	n = 583	n = 89
Response rate, %	31.2	37.1	33.7
Clinical improvement rate, %	47.0	57.3	56.2
Remission rate, %	16.7	19.1	9.0
Treatment-Resistant Subgroup	n = 258	n = 84
Response rate, %	23.3	38.1	34.5
Clinical improvement rate, %	39.9	58.3	56.0
Remission rate, %	12.4	20.2	8.3

Abbreviations: TMS Transcranial magnetic stimulation, UC Usual care

^aResponse rate is the percentage of the cohort with ≥ 50% improvement in PHQ-9 score from baseline to follow-up visit or from start to end of the TMS course. Clinical improvement rate is the percentage of the cohort with a decrease of ≥ 5 points on the PHQ-9 from baseline to follow-up visit or from start to end of the TMS course. Remission rate is the percentage of the sample with a PHQ-9 score < 5 at the follow-up visit or end of the TMS course